常用名 | 卡别多巴 | CAS号 | 28860-95-9 |
---|---|---|---|
价格 | ¥755.0/25mg ¥1745.0/100mg | 纯度 | 98.0% |
备货期 | 需询单 | 库存 | 现货 |
产品详情(用途,包装等)
用途: Carbidopa is an inhibitor of DOPA decarboxylase, which is used in parkinson disease.Target: DOPA decarboxylaseCarbidopa (CD), a competitive inhibitor of aromatic l-amino acid decarboxylase that does not cross the blood-brain barrier, is routinely administered with levodopa (LD) to patients with Parkinson disease (PD) to reduce the peripheral decarboxylation of LD to dopamine [1]. CD premedication improves 11C-5-HTP PET image quality and facilitates detection of NET lesions. Because of the similarity of metabolic pathways, this method could probably be applied to improve PET imaging using other tracers like 18F-DOPA and 11C-DOPA [2]. Carbidopa (100 microM) decreased growth of (but did not kill) SK-N-SH neuroblastoma and A204 rhabdomyosarcoma cells and did not affect proliferation of DU 145 prostate, MCF7 breast, or NCI-H460 large cell lung carcinoma lines. sublethal doses of carbidopa produced additive cytotoxic effects in carcinoid cells in combination with etoposide and cytotoxic synergy in SCLC cells when coincubated with topotecan [3]. 物理化学性质: CAS号:28860-95-9 常用中文名:卡别多巴 常用英文名:Carbidopa 分子式:C10H14N2O4 分子量:226.23 密度:1.4±0.1 g/cm3 沸点:528.7±50.0 °C at 760 mmHg 熔点:206 - 208ºC 闪点:273.5±30.1 °C 储存条件:库房低温通风干燥 |